

IDEA Collider: Innovation & Asymmetric Learning in Pharma
IDEA Pharma, SAI MedPartners
IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.
Episodes
Mentioned books

Oct 7, 2019 • 54min
IDEA Collider | John Carroll, Editor and Founder Endpoints News
John Carroll can be found at:@johncendpts on Twitter orwww.endpts.com

Sep 10, 2019 • 1h 4min
IDEA Collider | Safi Bahcall, Pharma Book Club
Opens with intro of Safi Bahcall
Discussion of leadership of innovation
S and P innovation
Pharmaceutical examples
Culture vs incentives
Serendipity and prediction


